REGENERON PHARMACEUTICALS, INC. Comprehensive Income
REGENERON PHARMACEUTICALS, INC. (REGN) reported Comprehensive Income of $1.25 billion for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-07-30
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-06-30 was $1.25B, a 11.72% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was $661.60M, a 21.77% decline year-over-year.
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was $853.10M, a 0.41% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was $1.48B, a 0.39% increase year-over-year.
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was $4.59B, a 2.33% increase from fiscal 2024.
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was $4.49B, a 9.10% increase from fiscal 2023.
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was $4.11B, a 0.35% decline from fiscal 2022.
- REGENERON PHARMACEUTICALS, INC. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was $4.13B, a 48.55% decline from fiscal 2021.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.25B 10-Q · filed 2026-07-30 | $1.91B 10-Q · filed 2026-07-30 | $2.76B derived: sum of 3 quarters · filed 2026-07-30 | $4.24B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $661.60M 10-Q · filed 2026-04-29 | $1.51B derived: sum of 2 quarters · filed 2026-04-29 | $2.99B derived: sum of 3 quarters · filed 2026-04-29 | $4.41B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $853.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $2.33B derived: sum of 2 quarters · filed 2026-02-04 | $3.74B derived: sum of 3 quarters · filed 2026-07-30 | $4.59B 10-K · filed 2026-02-04 | ||||
| 2025-09-30 | $1.48B 10-Q · filed 2025-10-28 | $2.89B derived: sum of 2 quarters · filed 2026-07-30 | $3.74B 10-Q · filed 2025-10-28 | $4.59B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $1.42B 10-Q · filed 2026-07-30 | $2.26B 10-Q · filed 2026-07-30 | $3.11B derived: sum of 3 quarters · filed 2026-07-30 | $4.58B derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $845.70M 10-Q · filed 2026-04-29 | $1.70B derived: sum of 2 quarters · filed 2026-04-29 | $3.17B derived: sum of 3 quarters · filed 2026-04-29 | $4.61B derived: sum of 4 quarters · filed 2026-04-29 | ||||
| 2024-12-31 | $849.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $2.32B derived: sum of 2 quarters · filed 2026-02-04 | $3.76B derived: sum of 3 quarters · filed 2026-02-04 | $4.49B 10-K · filed 2026-02-04 | ||||
| 2024-09-30 | $1.47B 10-Q · filed 2025-10-28 | $2.91B derived: sum of 2 quarters · filed 2025-10-28 | $3.64B 10-Q · filed 2025-10-28 | $4.89B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-06-30 | $1.44B 10-Q · filed 2025-08-01 | $2.17B 10-Q · filed 2025-08-01 | $3.42B derived: sum of 3 quarters · filed 2026-02-04 | $4.45B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2024-03-31 | $725.70M 10-Q · filed 2025-04-29 | $1.98B derived: sum of 2 quarters · filed 2026-02-04 | $3.01B derived: sum of 3 quarters · filed 2026-02-04 | $3.96B derived: sum of 4 quarters · filed 2026-02-04 | ||||
| 2023-12-31 | $1.26B derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-04 | $2.28B derived: sum of 2 quarters · filed 2026-02-04 | $3.24B derived: sum of 3 quarters · filed 2026-02-04 | $4.11B 10-K · filed 2026-02-04 | ||||
| 2023-09-30 | $1.03B 10-Q · filed 2024-10-31 | $1.98B derived: sum of 2 quarters · filed 2024-10-31 | $2.86B 10-Q · filed 2024-10-31 | $4.09B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-06-30 | $952.30M 10-Q · filed 2024-08-01 | $1.83B 10-Q · filed 2024-08-01 | $3.06B derived: sum of 3 quarters · filed 2025-02-05 | $4.33B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2023-03-31 | $875.00M 10-Q · filed 2024-05-02 | $2.11B derived: sum of 2 quarters · filed 2025-02-05 | $3.37B derived: sum of 3 quarters · filed 2025-02-05 | $4.17B derived: sum of 4 quarters · filed 2025-02-05 | ||||
| 2022-12-31 | $1.23B derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-05 | $2.50B derived: sum of 2 quarters · filed 2025-02-05 | $3.30B derived: sum of 3 quarters · filed 2025-02-05 | $4.13B 10-K · filed 2025-02-05 | ||||
| 2022-09-30 | $1.26B 10-Q · filed 2023-11-02 | $2.06B derived: sum of 2 quarters · filed 2023-11-02 | $2.89B 10-Q · filed 2023-11-02 | $5.09B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-06-30 | $798.40M 10-Q · filed 2023-08-03 | $1.63B 10-Q · filed 2023-08-03 | $3.82B derived: sum of 3 quarters · filed 2024-02-05 | $5.45B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2022-03-31 | $829.60M 10-Q · filed 2023-05-04 | $3.02B derived: sum of 2 quarters · filed 2024-02-05 | $4.65B derived: sum of 3 quarters · filed 2024-02-05 | $7.75B derived: sum of 4 quarters · filed 2024-02-05 | ||||
| 2021-12-31 | $2.19B derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-05 | $3.82B derived: sum of 2 quarters · filed 2024-02-05 | $6.92B derived: sum of 3 quarters · filed 2024-02-05 | $8.02B 10-K · filed 2024-02-05 | ||||
| 2021-09-30 | $1.63B 10-Q · filed 2022-11-03 | $4.72B derived: sum of 2 quarters · filed 2022-11-03 | $5.83B 10-Q · filed 2022-11-03 | $6.97B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-06-30 | $3.10B 10-Q · filed 2022-08-03 | $4.20B 10-Q · filed 2022-08-03 | $5.35B derived: sum of 3 quarters · filed 2023-02-06 | $6.19B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2021-03-31 | $1.10B 10-Q · filed 2022-05-04 | $2.25B derived: sum of 2 quarters · filed 2023-02-06 | $3.09B derived: sum of 3 quarters · filed 2023-02-06 | $4.03B derived: sum of 4 quarters · filed 2023-02-06 | ||||
| 2020-12-31 | $1.15B derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-06 | $1.99B derived: sum of 2 quarters · filed 2023-02-06 | $2.93B derived: sum of 3 quarters · filed 2023-02-06 | $3.52B 10-K · filed 2023-02-06 | ||||
| 2020-09-30 | $837.40M 10-Q · filed 2021-11-04 | $1.78B derived: sum of 2 quarters · filed 2021-11-04 | $2.37B 10-Q · filed 2021-11-04 | $3.17B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-06-30 | $941.90M 10-Q · filed 2021-08-05 | $1.54B 10-Q · filed 2021-08-05 | $2.33B derived: sum of 3 quarters · filed 2022-02-07 | $3.00B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2020-03-31 | $594.40M 10-Q · filed 2021-05-06 | $1.39B derived: sum of 2 quarters · filed 2022-02-07 | $2.06B derived: sum of 3 quarters · filed 2022-02-07 | $2.27B derived: sum of 4 quarters · filed 2022-02-07 | ||||
| 2019-12-31 | $796.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-07 | $1.47B derived: sum of 2 quarters · filed 2022-02-07 | $1.67B derived: sum of 3 quarters · filed 2022-02-07 | $2.15B 10-K · filed 2022-02-07 | ||||
| 2019-09-30 | $670.30M 10-Q · filed 2020-11-05 | $876.40M derived: sum of 2 quarters · filed 2020-11-05 | $1.35B 10-Q · filed 2020-11-05 | $2.17B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-06-30 | $206.10M 10-Q · filed 2020-08-05 | $682.30M 10-Q · filed 2020-08-05 | $1.50B derived: sum of 3 quarters · filed 2021-02-08 | $2.10B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2019-03-31 | $476.20M 10-Q · filed 2020-05-05 | $1.29B derived: sum of 2 quarters · filed 2021-02-08 | $1.89B derived: sum of 3 quarters · filed 2021-02-08 | $2.45B derived: sum of 4 quarters · filed 2021-02-08 | ||||
| 2018-12-31 | $818.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-08 | $1.41B derived: sum of 2 quarters · filed 2021-02-08 | $1.97B derived: sum of 3 quarters · filed 2021-02-08 | $2.44B 10-K · filed 2021-02-08 | ||||
| 2018-09-30 | $595.70M 10-Q · filed 2019-11-05 | $595.75M 10-Q · filed 2018-11-06 | $1.15B derived: sum of 2 quarters · filed 2019-11-05 | $1.62B 10-Q · filed 2019-11-05 | $1.62B 10-Q · filed 2018-11-06 | $1.77B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-06-30 | $555.40M 10-Q · filed 2019-08-06 | $555.39M 10-Q · filed 2018-08-02 | $1.02B 10-Q · filed 2019-08-06 | $1.02B 10-Q · filed 2018-08-02 | $1.17B derived: sum of 3 quarters · filed 2020-02-07 | $1.58B derived: sum of 4 quarters · filed 2020-02-07 | ||
| 2018-03-31 | $468.30M 10-Q · filed 2019-05-07 | $468.34M 10-Q · filed 2018-05-03 | $618.63M derived: sum of 2 quarters · filed 2020-02-07 | $1.03B derived: sum of 3 quarters · filed 2020-02-07 | $1.42B derived: sum of 4 quarters · filed 2020-02-07 | |||
| 2017-12-31 | $150.33M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-07 | $560.14M derived: sum of 2 quarters · filed 2020-02-07 | $956.11M derived: sum of 3 quarters · filed 2020-02-07 | $1.21B 10-K · filed 2020-02-07 | $1.21B 10-K · filed 2018-02-08 | |||
| 2017-09-30 | $409.80M 10-Q · filed 2018-11-06 | $805.78M derived: sum of 2 quarters · filed 2018-11-06 | $1.06B 10-Q · filed 2018-11-06 | $1.30B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-06-30 | $395.98M 10-Q · filed 2018-08-02 | $651.86M 10-Q · filed 2018-08-02 | $895.03M derived: sum of 3 quarters · filed 2019-02-07 | $1.15B derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2017-03-31 | $255.89M 10-Q · filed 2018-05-03 | $499.05M derived: sum of 2 quarters · filed 2019-02-07 | $755.75M derived: sum of 3 quarters · filed 2019-02-07 | $952.81M derived: sum of 4 quarters · filed 2019-02-07 | ||||
| 2016-12-31 | $243.16M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-07 | $499.87M derived: sum of 2 quarters · filed 2019-02-07 | $696.92M derived: sum of 3 quarters · filed 2019-02-07 | $874.10M 10-K · filed 2019-02-07 | $874.11M 10-K · filed 2017-02-09 | |||
| 2016-09-30 | $256.70M 10-Q · filed 2017-11-08 | $453.76M derived: sum of 2 quarters · filed 2017-11-08 | $630.94M 10-Q · filed 2017-11-08 | $786.78M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-06-30 | $197.06M 10-Q · filed 2017-08-03 | $374.24M 10-Q · filed 2017-08-03 | $530.08M derived: sum of 3 quarters · filed 2018-02-08 | $729.05M derived: sum of 4 quarters · filed 2018-02-08 | ||||
| 2016-03-31 | $177.18M 10-Q · filed 2017-05-04 | $161.53M 10-Q · filed 2016-05-05 | $333.02M derived: sum of 2 quarters · filed 2018-02-08 | $531.99M derived: sum of 3 quarters · filed 2018-02-08 | $697.88M derived: sum of 4 quarters · filed 2018-02-08 | |||
| 2015-12-31 | $155.84M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-08 | $354.81M derived: sum of 2 quarters · filed 2018-02-08 | $520.70M derived: sum of 3 quarters · filed 2018-02-08 | $592.38M 10-K · filed 2018-02-08 | ||||
| 2015-09-30 | $198.97M 10-Q · filed 2016-11-04 | $364.86M derived: sum of 2 quarters · filed 2016-11-04 | $436.53M 10-Q · filed 2016-11-04 | $551.98M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-06-30 | $165.89M 10-Q · filed 2016-08-04 | $237.57M 10-Q · filed 2016-08-04 | $353.02M derived: sum of 3 quarters · filed 2017-02-09 | $459.02M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2015-03-31 | $71.67M 10-Q · filed 2016-05-05 | $187.13M derived: sum of 2 quarters · filed 2017-02-09 | $293.13M derived: sum of 3 quarters · filed 2017-02-09 | $392.28M derived: sum of 4 quarters · filed 2017-02-09 | ||||
| 2014-12-31 | $115.45M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-09 | $221.46M derived: sum of 2 quarters · filed 2017-02-09 | $320.61M derived: sum of 3 quarters · filed 2017-02-09 | $391.56M 10-K · filed 2017-02-09 | $401.51M 10-K · filed 2015-02-12 | |||
| 2014-09-30 | $106.01M 10-Q · filed 2015-11-04 | $102.35M 10-Q · filed 2014-11-04 | $205.16M derived: sum of 2 quarters · filed 2015-11-04 | $276.11M 10-Q · filed 2015-11-04 | $265.98M 10-Q · filed 2014-11-04 | $363.96M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-06-30 | $99.15M 10-Q · filed 2015-08-04 | $95.53M 10-Q · filed 2014-08-05 | $170.11M 10-Q · filed 2015-08-04 | $163.63M 10-Q · filed 2014-08-05 | $257.95M derived: sum of 3 quarters · filed 2016-02-11 | $399.84M derived: sum of 4 quarters · filed 2016-02-11 | ||
| 2014-03-31 | $70.96M 10-Q · filed 2015-05-07 | $68.10M 10-Q · filed 2014-05-08 | $158.80M derived: sum of 2 quarters · filed 2016-02-11 | $300.69M derived: sum of 3 quarters · filed 2016-02-11 | $386.28M derived: sum of 4 quarters · filed 2016-02-11 | |||
| 2013-12-31 | $87.84M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | $229.73M derived: sum of 2 quarters · filed 2016-02-11 | $315.32M derived: sum of 3 quarters · filed 2016-02-11 | $413.72M 10-K · filed 2016-02-11 | $424.34M 10-K · filed 2014-02-13 | |||
| 2013-09-30 | $141.88M 10-Q · filed 2014-11-04 | $227.47M derived: sum of 2 quarters · filed 2014-11-04 | $325.87M 10-Q · filed 2014-11-04 | $797.02M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-06-30 | $85.59M 10-Q · filed 2014-08-05 | $183.99M 10-Q · filed 2014-08-05 | $655.13M derived: sum of 3 quarters · filed 2015-02-12 | $847.07M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2013-03-31 | $98.40M 10-Q · filed 2014-05-08 | $569.54M derived: sum of 2 quarters · filed 2015-02-12 | $761.48M derived: sum of 3 quarters · filed 2015-02-12 | $837.18M derived: sum of 4 quarters · filed 2015-02-12 | ||||
| 2012-12-31 | $471.14M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-12 | $663.08M derived: sum of 2 quarters · filed 2015-02-12 | $738.79M derived: sum of 3 quarters · filed 2015-02-12 | $750.97M 10-K · filed 2015-02-12 | ||||
| 2012-09-30 | $191.94M 10-Q · filed 2013-11-05 | $267.64M derived: sum of 2 quarters · filed 2013-11-05 | $279.82M 10-Q · filed 2013-11-05 | $226.25M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-06-30 | $75.71M 10-Q · filed 2013-08-06 | $87.89M 10-Q · filed 2013-08-06 | $34.31M derived: sum of 3 quarters · filed 2014-02-13 | -$28.88M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2012-03-31 | $12.18M 10-Q · filed 2013-05-03 | -$41.40M derived: sum of 2 quarters · filed 2014-02-13 | -$104.59M derived: sum of 3 quarters · filed 2014-02-13 | -$165.82M derived: sum of 4 quarters · filed 2014-02-13 | ||||
| 2011-12-31 | -$53.57M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-13 | -$116.77M derived: sum of 2 quarters · filed 2014-02-13 | -$178.00M derived: sum of 3 quarters · filed 2014-02-13 | -$221.13M 10-K · filed 2014-02-13 | ||||
| 2011-09-30 | -$63.19M 10-Q · filed 2012-10-24 | -$124.43M derived: sum of 2 quarters · filed 2012-10-24 | -$167.56M 10-Q · filed 2012-10-24 | -$184.47M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-06-30 | -$61.23M 10-Q · filed 2012-07-25 | -$104.36M 10-Q · filed 2012-07-25 | -$121.28M derived: sum of 3 quarters · filed 2013-02-15 | -$155.02M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2011-03-31 | -$43.13M 10-Q · filed 2012-04-26 | -$60.04M derived: sum of 2 quarters · filed 2013-02-15 | -$93.79M derived: sum of 3 quarters · filed 2013-02-15 | -$120.28M derived: sum of 4 quarters · filed 2013-02-15 | ||||
| 2010-12-31 | -$16.91M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | -$50.66M derived: sum of 2 quarters · filed 2013-02-15 | -$77.15M derived: sum of 3 quarters · filed 2013-02-15 | -$108.00M 10-K · filed 2013-02-15 | ||||
| 2010-09-30 | -$33.74M 10-Q · filed 2011-10-27 | -$60.24M derived: sum of 2 quarters · filed 2011-10-27 | -$91.09M 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | -$26.50M 10-Q · filed 2011-07-28 | -$57.35M 10-Q · filed 2011-07-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 |